Appelbaum Kevin J's Form 4 filing
Better Therapeutics, Inc. (BTTX) · filed Dec 22, 2021
- Accession no.
- 0000899243-21-049425
- Filed
- Dec 22, 2021, 6:03 PM ET
- Trade date
- Dec 20, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.60K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Appelbaum Kevin JCIK 0001547557 | Director, Officer (Chief Executive Officer), 10% Owner |
| Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amendedCIK 0001890904 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Common Stock | PPurchaseAcquired | +1,000 | $4.60 | +$4,599.9 | 3,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.